Mammalian Cells Segment Held Largest Share of North America Bioreactor Market in 2019
According to our new market research study on “North America Bioreactors Marketto 2027 – Regional Analysis and Forecast – by Cell, Molecule, Technology,and End User,”the market is expected to reach US$ 2,102.75 Mn by 2027 from US$ 1,188.50 Mn in 2019; it is estimated to grow at a CAGR of 7.5% from 2020 to 2027. The report provides trends prevailing in the North Americabioreactors market and the factors driving the market growth along with those hindering it.
The North Americabioreactors market, based on the cell, is segmented into mammalian cells, bacterial cells, yeast cells,and others.The mammalian cells segment held the largest share of the market in 2019, and the yeast cell segment estimated to register the highest CAGR in the market during the forecast period.The projected growth of the yeast cellssegment is attributed to the increased use of these cells as a single culture, or along with other probiotic strains,in probiotic production. Moreover, mounting research activities related to the industrial-scale production of probiotic yeasts would boost the growth of the market for this segment in the coming years.
The growth of the North Americabioreactors marketis mainly attributed to the increasing adoption of single-use bioreactors and rapidly growing demand for bioreactors from biopharmaceutical and biotechnology industries. However, stringent regulatory framework is the major factor hindering the market growth in North America.
A few of the leading companies operating in the North Americabioreactors market are Thermo Fisher Scientific Inc., Pall Corporation, PBS Biotech, Inc, General Electric Company,and MERCK KGaA.
North America Bioreactors Market, By Country, 2019 (%)
North America Bioreactors Market to Grow at a CAGR of 7.5% to reach US$ 2,102.75 Mn from 2020 to 2027
Download Free Sample
North America Bioreactors Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, and Others); Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, and Others); Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column, Others); End User [Research and development organizations, Biopharma Manufacturers, and Contract Manufacturing Organizations (CMOs)] and Country
North America Bioreactors Market to Grow at a CAGR of 7.5% to reach US$ 2,102.75 Mn from 2020 to 2027
Download Free SampleNorth America Bioreactors Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, and Others); Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, and Others); Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column, Others); End User [Research and development organizations, Biopharma Manufacturers, and Contract Manufacturing Organizations (CMOs)] and Country
The report segments North Americabioreactorsmarketas follows:
North AmericaBioreactors Market– ByCell
- Mammalian Cells
- Bacterial Cells
- Yeast Cells
- Others
North AmericaBioreactors Market– ByMolecule
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Stem Cells
- Gene Therapy
- Others
North America Bioreactors Market – ByTechnology
- Wave-Induced Motion SUB
- Stirred SUB
- Single-Use Bubble Column
- Others
North America Bioreactors Market – By End-users
- Biopharma Manufacturers
- Research and Development Organizations
- Contract Manufacturing Organisations (CMOs)
North AmericaBioreactors Market– By Country
- North America
- US
- Canada
- Mexico
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com